Spots Global Cancer Trial Database for stage iv endometrial carcinoma

Every month we try and update this database with for stage iv endometrial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00003946	Endometrial Can...	danazol	-	GOG Foundation
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer	NCT00258362	Endometrial Can...	carboplatin docetaxel radiation thera...	18 Years -	Masonic Cancer Center, University of Minnesota
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery	NCT00448643	Endometrial Can...	Vaginal Brachyt... Cisplatin Whole Abdominal...	18 Years - 80 Years	University of Miami
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer	NCT00287885	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer	docetaxel	18 Years -	Masonic Cancer Center, University of Minnesota
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer	NCT00245050	Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	pyridoxine hydr... Placebo doxorubicin HCL...	-	Case Comprehensive Cancer Center
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00005861	Endometrial Can...	pegylated lipos...	-	GOG Foundation
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer	NCT00030485	Endometrial Can...	erlotinib hydro...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors	NCT00004082	Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton...	carboplatin docetaxel gemcitabine hyd...	18 Years -	National Cancer Institute (NCI)
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer	NCT00118300	Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer	capecitabine brachytherapy radiation thera...	18 Years -	Case Comprehensive Cancer Center
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer	NCT00770185	Endometrial Can...	ridaforolimus gene expression... immunohistochem... laboratory biom...	18 Years -	Canadian Cancer Trials Group
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer	NCT00003127	Endometrial Can...	amifostine trih... carboplatin paclitaxel	16 Years -	SWOG Cancer Research Network
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)	NCT00085332	Endometrial Can...	docetaxel	-	GOG Foundation
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer	NCT00016341	Endometrial Can...	filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra...	-	GOG Foundation
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer	NCT00905658	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	therapeutic nut... standard follow...	18 Years - 65 Years	National Cancer Institute (NCI)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer	NCT00005842	Cancer	trastuzumab tipifarnib	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract	NCT00003334	Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	paclitaxel pegylated lipos...	- 120 Years	NYU Langone Health
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer	NCT00470067	Endometrial Can...	carboplatin pegylated lipos...	18 Years -	Roswell Park Cancer Institute
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery	NCT00448643	Endometrial Can...	Vaginal Brachyt... Cisplatin Whole Abdominal...	18 Years - 80 Years	University of Miami
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer	NCT00002493	Endometrial Can... Psychosocial Ef...	cisplatin doxorubicin hyd... low-LET photon ...	-	GOG Foundation
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer	NCT00032162	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	carboplatin pegylated lipos...	18 Years -	AGO Study Group
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors	NCT00019331	Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu...	aldesleukin ras peptide can... sargramostim DetoxPC	18 Years -	National Cancer Institute (NCI)
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer	NCT00003135	Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer	fluorouracil pegylated lipos... hyperthermia tr...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer	NCT00016341	Endometrial Can...	filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra...	-	GOG Foundation
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma	NCT00002465	Breast Cancer Endometrial Can... Malignant Mesot...	megestrol aceta...	18 Years -	National Cancer Institute (NCI)
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00003691	Endometrial Can...	filgrastim cisplatin doxorubicin hyd... paclitaxel	18 Years -	GOG Foundation
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract	NCT00003334	Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma	paclitaxel pegylated lipos...	- 120 Years	NYU Langone Health
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00083213	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer	NCT00245050	Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi...	pyridoxine hydr... Placebo doxorubicin HCL...	-	Case Comprehensive Cancer Center
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT00087100	Endometrial Can...	pemetrexed diso...	-	GOG Foundation
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis	NCT00002949	Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer	paclitaxel vinorelbine tar... radiation thera...	18 Years -	University of Chicago
Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer	NCT00870337	Endometrial Can...	everolimus	18 Years -	ARCAGY/ GINECO GROUP
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer	NCT00107445	Primary Periton... Stage I Endomet... Stage I Ovarian... Stage IA Cervic... Stage IB Cervic... Stage II Endome... Stage II Ovaria... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Endom... Stage III Ovari... Stage IV Endome... Stage IV Ovaria... Stage IVA Cervi... Stage IVB Cervi...	EF5	18 Years -	National Cancer Institute (NCI)
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer	NCT00003624	Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma	amifostine trih... cisplatin paclitaxel	-	GOG Foundation
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer	NCT00003439	Cancer	recombinant int...	18 Years -	National Cancer Institute (NCI)
Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer	NCT00905658	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	therapeutic nut... standard follow...	18 Years - 65 Years	National Cancer Institute (NCI)
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer	NCT00003624	Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma	amifostine trih... cisplatin paclitaxel	-	GOG Foundation
Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00006377	Endometrial Can...	carboplatin doxorubicin hyd... paclitaxel	18 Years -	Memorial Sloan Kettering Cancer Center
Gene Therapy in Treating Patients With Cancer	NCT00004178	Cancer	therapeutic aut...	18 Years -	Roger Williams Medical Center
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00005861	Endometrial Can...	pegylated lipos...	-	GOG Foundation
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer	NCT01150682	Endometrial Can...	RNA analysis reverse transcr... enzyme-linked i... immunohistochem... laboratory biom...	-	National Cancer Institute (NCI)
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00095979	Endometrial Ade... Recurrent Endom... Stage IV Endome...	ixabepilone	-	National Cancer Institute (NCI)
Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis	NCT00002949	Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer	paclitaxel vinorelbine tar... radiation thera...	18 Years -	University of Chicago
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients	NCT00253383	Cancer	counseling inte... educational int... psychosocial as... quality-of-life...	18 Years -	Dartmouth-Hitchcock Medical Center
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer	NCT00055705	Cancer	PV701	18 Years -	National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity	NCT00003548	Cancer	aminocamptothec...	18 Years -	NYU Langone Health
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer	NCT00003946	Endometrial Can...	danazol	-	GOG Foundation
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer	NCT00004251	Endometrial Can...	letrozole	18 Years - 120 Years	Canadian Cancer Trials Group
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer	NCT00002493	Endometrial Can... Psychosocial Ef...	cisplatin doxorubicin hyd... low-LET photon ...	-	GOG Foundation
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer	NCT00470067	Endometrial Can...	carboplatin pegylated lipos...	18 Years -	Roswell Park Cancer Institute
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00082823	Cancer	ziv-aflibercept	18 Years - 120 Years	Regeneron Pharmaceuticals
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	NCT00031681	Advanced Adult ... Carcinoma of th... Estrogen Recept... Extensive Stage... Gastrointestina... HER2-negative B... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Progesterone Re... Recurrent Adeno... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Borde... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Endom... Recurrent Esoph... Recurrent Esthe... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Small... Recurrent Small... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Small Intestine... Small Intestine... Small Intestine... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Border... Stage IV Breast... Stage IV Colon ... Stage IV Endome... Stage IV Esopha... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Triple-negative... Unresectable Ex... Unresectable Ga... Unspecified Adu... Untreated Metas...	7-hydroxystauro... irinotecan hydr... diagnostic labo...	18 Years -	National Cancer Institute (NCI)
Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00095979	Endometrial Ade... Recurrent Endom... Stage IV Endome...	ixabepilone	-	National Cancer Institute (NCI)
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery	NCT00842452	Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer	topotecan hydro... pharmacological...	18 Years -	Case Comprehensive Cancer Center
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery	NCT01939028	Stage I Endomet... Stage II Endome... Stage III Endom... Stage IV Endome...	lymph node mapp... sentinel lymph ... isosulfan blue indocyanine gre... therapeutic con... lymphadenectomy	-	Case Comprehensive Cancer Center
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma	NCT00101972	Cancer	monoclonal anti...	18 Years -	MacroGenics
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors	NCT00499291	Cancer	paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai...	18 Years - 120 Years	Eastern Cooperative Oncology Group

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: